Filter
508
Text search:
Therapie
Featured
Recommendations
60
New Publications
68
Language
Document type
No document type
150
Guidelines
98
Studies & Reports
95
Fact sheets
41
Strategic & Response Plan
25
Resource Platforms
21
Brochures
19
Training Material
18
Manuals
17
Infographics
10
Videos
8
Online Courses
5
Situation Updates
1
Countries / Regions
Germany
131
Global
75
Western and Central Europe
14
Africa
12
Malawi
9
South Africa
7
Senegal
4
India
4
Tanzania
4
Namibia
4
North America
4
Kenya
3
Benin
3
Switzerland
3
Ukraine
3
Eastern Europe
3
Nigeria
2
Congo, Democratic Republic of
2
Uganda
2
Zimbabwe
2
Cambodia
2
Mozambique
2
Brazil
2
South–East Asia Region
2
Latin America and the Carribbean
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
USA
1
Ethiopia
1
Ghana
1
Haiti
1
Zambia
1
Chad
1
Thailand
1
Rwanda
1
Austria
1
Madagascar
1
West and Central Africa
1
Asia
1
Venezuela
1
Southern Africa
1
Laos
1
Russia
1
Vietnam
1
Guyana
1
Authors & Publishers
Publication Years
Category
Public Health
83
Countries
83
Clinical Guidelines
27
Capacity Building
21
Women & Child Health
7
Key Resources
4
Pharmacy & Technologies
4
Toolboxes
Refugee
120
NCDs
91
Malaria
74
Mental Health
56
HIV
47
TB
29
COVID-19
22
Global Health Education
18
Cholera
13
NTDs
10
Conflict
5
Rapid Response
5
Pharmacy
5
Health Financing Toolbox
5
Ebola & Marburg
4
Zika
2
Caregiver
2
2.0 Rapid Response
2
Disability
1
Specific Hazards
1
Planetary Health
1
Ensure treatment decisions are timely, rely on evidence-based guidelines, capture key elements within the social determinants of health, and are made collaboratively with people with diabetes and care partners based on individual preferences, prognoses, comorbidities, and informed financial conside
...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera
...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im
...
Heart failure (HF) is a global public health concern with disproportionate socioeconomic, morbidity and mortality burden on low- and middle-income countries (LMICs). This review summarises contemporary data on the demographic and clinical characteristics, aetiologies, treatment, economic burden and
...
Demographic and socioeconomic data Progress towards HIV testing and treatment cascade targets by 2025 (2023) Health sector cascade (2023) Estimated number of people newly infected with HIV
The number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.
The global prevalence of diabetes* among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014.
Diabetes prevalence has been rising more rapidly in middle- and low-income countries.
Dia
...
Every November 14, World Diabetes Day is commemorated. This is an opportunity to raise awareness about the impact of diabetes on the health of people and to highlight the opportunities to strengthen the prevention, diagnosis, and treatment of diabetes.
Cardiovascular disease (CVD), also called heart and circulatory disease, is an umbrella name for conditions that affect your heart or circulation. These include high blood pressure, stroke and vascular dementia.
Zambia has completed the implementation of the National TB Strategic Plan (2017-2021) that set in motion the TB elimination agenda in Zambia through coordinated and accelerated TB response. During this period, the National TB and Leprosy Programme (NTLP) registered tremendous success.
The NTLP is
...
2ieme edtion. Cette deuxième édition s'appuie sur l'expérience de plus de 10 ans de déploiement de la CPS et reflète les changements introduits dans les lignes directrices de l'OMS pour le paludisme, le 3 juin 2022. L'objectif de cette publication est de partager ces bonnes pratiques afin d'am
...
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and
...
The WHO recommends parenteral artesunate over quinine and artemether for treating severe Plasmodium falciparum malaria in adults and children. Intravenous administration is preferred. A new one-step, arginine-based formulation eliminates the need for dilution steps, reducing errors and accelerating
...
Mozambique was the first country outside of the Sahel to successfully implement seasonal malaria chemoprevention (SMC) on a large scale. This learning paper captures some of the lessons drawn from the implementation process.
Moçambique foi o primeiro país fora da região do Sahel a expandir com sucesso a quimioprevenção sazonal da malária (QSM). Neste documento de aprendizagem, descrevemos as lições decorrentes da aplicação em larga escala da QSM em Moçambique.
Where malaria transmission is seasonal, notably in Africa’s Sahel region, children of all ages most at risk of severe malaria are protected through SMC. This intervention consists of full antimalarial treatment courses of sulfadoxine-pyrimethamine and amodiaquine (SPAQ), administered monthly (28 d
...
Report of a virtual meeting 21–23 June 2022
WHO has updated it recommendations for 3 key malaria prevention strategies: seasonal malaria chemoprevention (SMC), perennial malaria chemoprevention (PMC – previously known as intermittent preventive treatment in infants, or IPTi) and intermittent preventive treatment of malaria in pregnancy (IPT
...
